Tit Albreht, MD, PhD, National Institute of Public Health, Ljubljana, Slovenia, discusses screening for prostate cancer and identifying which populations should be screened. This interview took place at the EAU congress in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.